Fosrenol - 54092-253-90 - (lanthanum carbonate)

Alphabetical Index


Drug Information of Fosrenol

Product NDC: 54092-253
Proprietary Name: Fosrenol
Non Proprietary Name: lanthanum carbonate
Active Ingredient(s): 750    mg/1 & nbsp;   lanthanum carbonate
Administration Route(s): ORAL
Dosage Form(s): TABLET, CHEWABLE
Coding System: National Drug Codes(NDC)

Labeler Information of Fosrenol

Product NDC: 54092-253
Labeler Name: Shire US Manufacturing Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021468
Marketing Category: NDA
Start Marketing Date: 20051123

Package Information of Fosrenol

Package NDC: 54092-253-90
Package Description: 6 BOTTLE in 1 PACKAGE (54092-253-90) > 15 TABLET, CHEWABLE in 1 BOTTLE (54092-253-15)

NDC Information of Fosrenol

NDC Code 54092-253-90
Proprietary Name Fosrenol
Package Description 6 BOTTLE in 1 PACKAGE (54092-253-90) > 15 TABLET, CHEWABLE in 1 BOTTLE (54092-253-15)
Product NDC 54092-253
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name lanthanum carbonate
Dosage Form Name TABLET, CHEWABLE
Route Name ORAL
Start Marketing Date 20051123
Marketing Category Name NDA
Labeler Name Shire US Manufacturing Inc.
Substance Name LANTHANUM CARBONATE
Strength Number 750
Strength Unit mg/1
Pharmaceutical Classes Phosphate Binder [EPC],Phosphate Chelating Activity [MoA]

Complete Information of Fosrenol


General Information